Affordability in Cancer Care with 4baseCare

▴
4baseCare is an onco-tech company that creates an ecosystem of patients, oncologists and researchers. It provides a first-of-its-kind gene panel test specifically created for the Indian population.

Annually, 1.5 million Indians get diagnosed with cancer. These numbers have to suffer not only from the disease but also the price tag that comes with it. Affordability in cancer care is rare. Targeted and personalised solutions in cancer are important but this pushes the price of treatments up. 

While working in a pharmaceutical company, Hitesh Goswami and Kshitij Datta Rishi met. The former was a neurobiologist and the latter a biotechnologist. They sought to tackle this mammoth of a problem. Together they decided to tackle affordability in oncology with 4baseCare. Goswami had always been interested in genomics and its application. Whereas, Kshitij had experience with working in two healthcare companies. 

4baseCare is an onco-tech company that creates an ecosystem of patients, oncologists and researchers. They developed genomic panels that help provide patients with targeted therapy using advanced genomics and digital health technology. With genomics, one can create personalised and precision solutions that target the patient’s cancer. It hosts specialists from India, USA and Singapore. 

Where a gene panel test would cost Rs 1.5 to 2.5 lakhs, 4baseCare provides the same in 1/4th the price. With affordability, their gene panel test is first-of-its-kind as it is specifically created for the Indian population. 

They were the part of the Illumina Accelerator programme and had raised an undisclosed amount in seed round. Other investors were Dheeraj Jain (MD of Redcliffe Lifesciences) and Lalit Wadhwa. The US-based investment firm, First-In-Venture, also gave seed funding. 

In its pre-Series A round, Mount Judi Ventures, growX ventures, Season Two Ventures, First-In-Venture, and other angel investors raised $2 million. Besides strengthening its R&D and operations, the funds will be used to expand its genomics test portfolio and its presence in Asia.

Will the affordability of 4baseCare help millions of Indians defeat cancer with personalised and affordable treatment?

Tags : #4baseCare #HiteshGoswami #KshitijDattaRishi #growXventures #SeasonTwoVentures #First-InVenture #MountJudiVentures #funding #MediSpeak #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026